Long-term survival of childhood cancer has improved considerably, from 20% in the 1940s,
1 to 70% to 80%
2-5 at present, owing to chemotherapy, radiotherapy, supportive therapy, and combined modality treatment. Unfortunately, improved survival is accompanied by the occurrence of late treatment effects.
6-8 Cardiovascular disease (CVD) and cardiac mortality are among the most serious late effects. Several population-based studies observed a 6- to 8-fold increased mortality owing to CVD among childhood cancer survivors (CCSs) compared with the general population.
9-11